跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
PANHEMATIN
Authorized
STANDARD
PANHEMATIN
recordati rare diseases canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
1f720fc1ba7ffb0f
Company
recordati rare diseases canada inc
Type
Standard
Approval Details
Approval Id
1f720fc1ba7ffb0f
Drug Approval Canada Name
PANHEMATIN
Product Name
PANHEMATIN
Status
Marketed
Status Date
2018-12-05
Original Market Date
2018-12-05
Din
02478765
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Prescription , Schedule D
Atc Original
B06AB01 HEMATIN
Atc Name
b 06 ab 01
Aig Number
0160470001
Company Name
recordati rare diseases canada inc
Company Address
3080 Yonge Street, Suite 6060, Toronto, Ontario, Canada, M4N 3N1
Active Ingredients
HEMIN
268 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
1f720fc1ba7ffb0f
Type
Standard
Back to Health Canada Approvals
PANHEMATIN - Health Canada Drug Approval Details